MyAverix Finance
US · Healthcare
Rebus Holdings Inc. (RBSH)
Biotechnology
Rebus Holdings Inc. (RBSH) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RBSH
Rebus Holdings Inc. (RBSH) — FAQ
What is RBSH's P/E ratio?
The price-to-earnings (P/E) ratio for Rebus Holdings Inc. (RBSH) is 25.00 (data as of 2026-05-23).
Does Rebus Holdings Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Rebus Holdings Inc. (RBSH). Check the MyAverix Finance app for the latest dividend data.
What sector is Rebus Holdings Inc. in?
Rebus Holdings Inc. (RBSH) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RBSH listed on?
RBSH is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.